Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
Since the beginning of the SARS-CoV-2(severe acute respiratory syndrome-coronavirus-2) pandemic, arace to develop a vaccine has been initiated, considering the massive and rather significant economic and healthcare hits that this virus has caused. The pathophysiology occurring following COVID-19(cor...
Main Authors: | Sawsan Elgohary, Aya A. Elkhodiry, Nada S. Amin, Ulrike Stein, Hend M. El Tayebi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/2/302 |
Similar Items
-
Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure
by: Badary OA, et al.
Published: (2021-05-01) -
New Coronavirus COVID-19 (SARS-CoV-2)
by: O. V. Shamsheva
Published: (2020-03-01) -
Prevalence of SARS-CoV-2 among community members presenting for testing in Peoria, Illinois from 21 April to 15 May 2020
by: Tulika Chatterjee, et al.
Published: (2021-01-01) -
Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key
by: Salah T. Al Awaidy
Published: (2021-03-01) -
SARS-CoV 2 in Cellular Level: Do we dominate the whole picture and how can we intervene?
by: Elif Menekşe, et al.
Published: (2021-03-01)